AAV-Mediated APOE4 Gene Silencing to Treat Homozygous APOE4-Associated Alzheimer's Disease

被引：0
|
作者：
Karan, Kalpita R. [1 ]
Kebret, Mara R. [1 ]
Hackett, Neil R. [1 ]
Crystal, Ronald G. [1 ]
机构：
[1] Weill Cornell Med Coll, Genet Med, New York, NY USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1122
引用
收藏
页码：533 / 533
页数：1
相关论文
共 50 条
  • [1] AAV-Mediated APOE Gene Silencing for Alzheimer's Disease
    Hentschel, Lisa
    Oudshoorn-Dickmann, Maroeska
    Wattimury, Hendrina
    Boggiani, Lorenzo
    Moreno, Fiona
    Tripathi, Shrijana
    Pereira, Ines Lopes
    Nogueira, Ana
    Peris, Sara Gimeno
    Villamil, Javier
    Spronck, Lisa
    Bosma, Bas
    Kusuma, Angga
    Dobrynin, Greg
    Liu, Ying Poi
    MOLECULAR THERAPY, 2022, 30 (04) : 433 - 434
  • [2] Second Generation AAV-Mediated Gene Therapy to Mitigate Risk for Alzheimer's Disease in APOE4/4Homozygotes
    Montel, Rachel A.
    Frenk, Esther
    Crystal, Ronald G.
    Stiles, Katie M.
    MOLECULAR THERAPY, 2022, 30 (04) : 395 - 395
  • [3] Second Generation APOE2+APOE4- AAV-Mediated Gene Therapy for APOE Homozygotes at Risk for Alzheimer's Disease
    Montel, Rachel
    Frenk, Esther
    Crystal, Ronald G.
    Stiles, Katie M.
    MOLECULAR THERAPY, 2021, 29 (04) : 167 - 168
  • [4] Editorial: APOE4-associated heterogeneity in the pathogenesis of Alzheimer's disease
    Torres, Eileen Ruth Samson
    Rebeck, G. William
    Nuriel, Tal
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [5] AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease
    Rosenberg, Jonathan B.
    Kaplitt, Michael G.
    De, Bishnu P.
    Chen, Alvin
    Flagiello, Thomas
    Salami, Christiana
    Pey, Eduard
    Zhao, Lingzhi
    Arbona, Rodolfo J. Ricart
    Monette, Sebastien
    Dyke, Jonathan P.
    Balion, Douglas J.
    Kaminsky, Stephen M.
    Sondhi, Dolan
    Petsko, Gregory A.
    Paul, Steven M.
    Crystal, Ronald G.
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2018, 29 (01) : 24 - 47
  • [6] APOE4 testing for Alzheimer's disease
    Karlawish, JHT
    Sachs, GA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (09) : 1153 - 1154
  • [7] ApoE4: A RISK FACTOR FOR ALZHEIMER'S DISEASE
    Agarwala, A.
    Durakoglugil, M.
    Xian, D.
    Bowen, I
    Herz, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (02) : 469 - 469
  • [8] Suppression of Neurological Deterioration in the APP1.PSEN1/APOE4 Murine Model of Alzheimer's Disease by AAV-Mediated Expression of APOE2 Christchurch
    Gunaydin, Caner
    Lephart, Hailey C.
    Stiles, Katie M.
    Hackett, Neil R.
    Kaminsky, Stephen M.
    Sondhi, Dolan
    Crystal, Ronald G.
    MOLECULAR THERAPY, 2023, 31 (04) : 402 - 403
  • [9] Epigenetic Downregulation of ApoE4 for Alzheimer's Disease
    Asmus, Natalie
    Moncalvo, Malik
    Dong, Wendy
    Ilich, Ekaterina
    Falek, Carmel
    Rittiner, Joseph
    Tringali, Domenic
    Yun, Young
    Gu, Jeffrey
    Wei, Angela
    Yang, Anna
    Angrist, Misha
    Chiba-Falek, Ornit
    Kantor, Boris
    MOLECULAR THERAPY, 2020, 28 (04) : 430 - 430
  • [10] Alzheimer disease risk associated with APOE4 is modified by STH gene polymorphism
    Seripa, D
    Matera, MG
    D'Andrea, RP
    Gravina, C
    Masullo, C
    Daniele, A
    Bizzarro, A
    Rinaldi, M
    Antuono, P
    Wekstein, DR
    Dal Forno, G
    Fazio, VM
    NEUROLOGY, 2004, 62 (09) : 1631 - 1633
12345